The success of Patient-Centered Outcomes Research depends a great deal on the choice of appropriate Clinical Outcome Assessments (COAs). They should be selected by the domains they measure as well as the populations and the therapeutic areas they cover. Practical issues such as the availability of translations, copyrights, and access to instruments are also important considerations.
The PROQOLID™ Database was created in 2002 by Mapi Research Trust in view of providing a tool for a better knowledge, a relevant use of COAs, and to extend access to Patient Centered Outcomes resources for the scientific community.
PROQOLID™ is supplied exponentially with new instruments throughout the year, based on recommended sources such as FDA (The U.S. Food and Drug Administration), EMA (European Medicines Agency), and Research and Development scientific community.
It mainly focuses on the original COAs developed: it provides descriptive information on COAs as well as descriptions of COAs related to the original (if relevant). The adequacy of the study methodology and the psychometric properties are not evaluated.
The COAs presented in PROQOLID™ may have specific conditions of use and, if available, copies of the COAs are presented for review purposes only.
PROQOLID™ offers two levels of access:
PROQOLID™ does not provide copies of the COAs. In some cases, PROQOLID™ may provide review copies of COAs for information purposes only. Should users of PROQOLID™ wish to use a COA described in PROQOLID™, users shall contact the copyright holder of the COA and comply with the conditions of use of the COA.
The free access level presents basic information:
The member access level presents a greater degree of information on the instruments (if available):
In addition to these two levels, a tab named Related COA instrument facilitates browsing in PROQOLID™.
COAs distributed by Mapi Research Trust include the following additional information: